aortic dissecting aneurysm
Conditions
Interventions
Group 1:Surgeon-modified fenestrated/branched endografts
Group 2:Optimal medical therapy
Sponsors
Nanjing Drum Tower Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years; 2. Aortic CTA or DSA, Stanford type B aortic dissection was diagnosed, and the first operation was TEVAR; 3. Meet one of the following conditions: Follow-up after TEVAR operation: (1) The diameter of the false lumen increased, with the half-year >5mm and the total aortic diameter >4cm; (2) The diameter of the viscera is more than 10mm; (3) False lumen patency and partial thrombosis; (4) Manifestations of ischemia and threatened rupture of internal organs or lower limbs; 4. Patients can actively cooperate with follow-up visits; 5. Informed consent has been signed.
Exclusion criteria
Exclusion criteria: 1. ASA score V, or severe renal insufficiency or respiratory insufficiency; 2. Complicated with malignant tumor, severe infectious disease, hematological system disease, connective tissue disease; 3. Myocardial infarction or cerebrovascular accident occurred within 6 weeks; 4. Unstable angina pectoris; 5. Life expectancy is less than 1 year; 6. The presence of ischemia and threatened rupture of internal organs or lower limbs; 7. History of allergy to contrast agents or anticoagulants; 8. Poor treatment compliance or inability to participate in postoperative follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete thrombosis of false lumen; | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause mortality;Secondary intervention;False lumen increase;Stent-related adverse events;Other adverse events; | — |
Countries
China
Contacts
Public ContactLi Xiaoqiang
Nanjing Drum Tower Hospital
Outcome results
None listed